Veracyte (VCYT) Non-Current Deffered Revenue (2012 - 2022)

Veracyte has reported Non-Current Deffered Revenue for 10 years, with the latest figure at $278000.0 in Q1 2022.

• Non-Current Deffered Revenue for Q1 2022 came in at $278000.0, down 62.78% year-over-year; the trailing twelve-month figure through Mar 2022 was $278000.0 (down 62.78% YoY), and the FY2021 annual result was $343000.0, down 58.62% from the prior year.
• Non-Current Deffered Revenue eased to $278000.0 in Q1 2022, from $343000.0 in the prior quarter.
• Over five years, Non-Current Deffered Revenue peaked at $4.1 million in Q1 2018 and troughed at $278000.0 in Q1 2022.
• A 4-year average of $1.9 million and a median of $788000.0 in 2020 frame the typical range for Non-Current Deffered Revenue.
• The widest annual swing landed in 2018, when Non-Current Deffered Revenue declined 6.36%; it then sank 62.78% in 2022.
• A 4-year view of Non-Current Deffered Revenue shows it stood at $3.9 million in 2018, then plunged by 78.74% to $829000.0 in 2020, then plunged by 58.62% to $343000.0 in 2021, then fell by 18.95% to $278000.0 in 2022.
• Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $278000.0 in Q1 2022, $343000.0 in Q4 2021, and $552000.0 in Q3 2021.